SCHEMBL10186994

SCHEMBL10186994

CCCCC1NCC(C(=O)O)NC1=O

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
USP2 O75604 1/20 0.42
GAA P10253 1/20 0.42
SIRT2 Q8IXJ6 4/20 0.38
SIRT1 Q96EB6 4/20 0.38
SIRT3 Q9NTG7 4/20 0.38
S1PR3 Q99500 2/20 0.37
ITGB3 P05106 2/20 0.37
ITGA2B P08514 2/20 0.37
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
MAPT P10636 1/20 0.37
PKM P14618 1/20 0.37
HPGD P15428 1/20 0.37
KMT2A Q03164 1/20 0.37
GLB1 P16278 1/20 0.34
NAAA Q02083 4/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12572143 0.88 SIRT2 (0.40) ALDH1A1USP2GAASIRT2SIRT1
SCHEMBL12572105 0.88 SIRT2 (0.40) ALDH1A1USP2GAASIRT2SIRT1
SCHEMBL12572140 0.88 SIRT2 (0.40) ALDH1A1USP2GAASIRT2SIRT1
SCHEMBL13435356 0.88 SIRT2 (0.40) ALDH1A1USP2GAASIRT2SIRT1
SCHEMBL13170335 0.88 SIRT2 (0.40) ALDH1A1USP2GAASIRT2SIRT1
SCHEMBL12236158 0.84 SIRT2 (0.39) ALDH1A1USP2GAASIRT2SIRT1
SCHEMBL12236119 0.84 SIRT2 (0.36) ALDH1A1USP2GAASIRT2SIRT1
SCHEMBL13611032 0.84 SIRT2 (0.36) ALDH1A1USP2GAASIRT2SIRT1
SCHEMBL12236110 0.84 SIRT2 (0.36) ALDH1A1USP2GAASIRT2SIRT1
SCHEMBL12236087 0.84 SIRT2 (0.36) ALDH1A1USP2GAASIRT2SIRT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8114844-B2 Linear and cyclic melanocortin receptor-specific peptidomimetics PALATIN TECHNOLOGIES, INC. (US) 2012-02-14 US disclosed
US-8114844-B2 Linear and cyclic melanocortin receptor-specific peptidomimetics PALATIN TECHNOLOGIES, INC. (US) 2012-02-14 US disclosed
US-20090069224-A1 Linear and Cyclic Melanocortin Receptor-Specific Peptidomimetics PALATIN TECHNOLOGIES, INC. (US) 2009-03-12 US disclosed
US-20090069224-A1 Linear and Cyclic Melanocortin Receptor-Specific Peptidomimetics PALATIN TECHNOLOGIES, INC. (US) 2009-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069224-A1 Linear and Cyclic Melanocortin Receptor-Specific Peptidomimetics MC1R, MC3R, MC5R ALDH1A1 4472/4885USP2 3731/4885GAA 4572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.